Amgen gets approval for two plants

09/7/2005 | Reuters

Amgen said the FDA approved new manufacturing plants, with Amgen's Enbrel to be produced at a plant in Rhode Island and Neupogen and Neulasta to be manufactured at a new plant in Puerto Rico. The company also said it was building a second facility at the Puerto Rico site for production of its anemia drug, Epogen.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Roche
Marlborough, MA
Test Technician
Roche
Marlborough, MA